Jeisys Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	167,823	143,030	116,550	81,296	47,829
Other Revenue	-	-	-	-	0
Revenue	167,823	143,030	116,550	81,296	47,829
Revenue Growth (YoY)	34.57%	22.72%	43.36%	69.97%	-
Cost of Revenue	50,798	44,138	37,035	24,714	14,137
Gross Profit	117,025	98,891	79,515	56,582	33,692
Selling, General & Admin	70,937	55,659	39,961	28,279	18,783
Research & Development	3,392	2,748	2,507	2,193	1,134
Other Operating Expenses	673.21	710.44	441.15	418.52	274.46
Operating Expenses	78,863	62,578	45,599	32,978	22,843
Operating Income	38,162	36,314	33,915	23,604	10,849
Interest Expense	-341	-222.44	-391.25	-387.98	-980.57
Interest & Investment Income	372.23	124.73	33.12	32.64	17.32
Currency Exchange Gain (Loss)	286.31	-574.51	164.68	190.6	-317.75
Other Non Operating Income (Expenses)	-72.02	-35.45	-67.6	-10,568	-1,031
EBT Excluding Unusual Items	38,408	35,606	33,654	12,872	8,537
Gain (Loss) on Sale of Investments	-82.46	-83.03	295.45	239.53	10.02
Gain (Loss) on Sale of Assets	-32.37	-24.71	-63.69	-17.85	-331.99
Pretax Income	38,293	35,498	33,886	13,093	8,215
Income Tax Expense	9,847	10,390	6,874	-667.11	1,064
Earnings From Continuing Operations	28,446	25,108	27,012	13,761	7,151
Earnings From Discontinued Operations	-	-	-	-267.94	391.31
Net Income to Company	28,446	25,108	27,012	13,493	7,543
Minority Interest in Earnings	-476.29	-307.49	117.49	98.98	-
Net Income	27,969	24,800	27,130	13,592	7,543
Net Income to Common	27,969	24,800	27,130	13,592	7,543
Net Income Growth	7.34%	-8.59%	99.61%	80.20%	-
Shares Outstanding (Basic)	77	76	71	70	55
Shares Outstanding (Diluted)	77	77	77	77	55
Shares Change (YoY)	0.33%	0.93%	-0.42%	40.97%	-
EPS (Basic)	365.52	328.40	380.50	194.32	138.09
EPS (Diluted)	361.97	322.26	370.28	176.67	138.09
EPS Growth	3.36%	-12.97%	109.59%	27.94%	-
Free Cash Flow	10,879	18,387	12,823	17,910	13,673
Free Cash Flow Per Share	140.86	237.58	167.23	232.60	250.32
Gross Margin	69.73%	69.14%	68.22%	69.60%	70.44%
Operating Margin	22.74%	25.39%	29.10%	29.04%	22.68%
Profit Margin	16.67%	17.34%	23.28%	16.72%	15.77%
Free Cash Flow Margin	6.48%	12.86%	11.00%	22.03%	28.59%
EBITDA	42,694	40,577	36,956	26,079	13,178
EBITDA Margin	25.44%	28.37%	31.71%	32.08%	27.55%
D&A For EBITDA	4,531	4,263	3,041	2,474	2,329
EBIT	38,162	36,314	33,915	23,604	10,849
EBIT Margin	22.74%	25.39%	29.10%	29.04%	22.68%
Effective Tax Rate	25.72%	29.27%	20.29%	-	12.95%
Advertising Expenses	-	7,701	6,232	3,647	1,450

Source: S&P Capital IQ. Standard template. Financial Sources.